Abstract
Complement regulators and receptors can be identified individually in tissues by probing thin (5 μm) tissue sections fixed on a solid glass support with appropriate antibodies. The bound antibodies are visualized with a proper label that has been attached to the primary antibody itself or to a secondary antibody against the primary immunoglobulin (see Note 1). Despite the label the antibody retains its reactivity with its antigen. In immunofluorescence microscopy the label is a fluorochrome that emits visible light under exposure to exciting radiation like ultraviolet (UV) light. Washing out the extra stain reveals the sites where antibody has contacted the antigen. These sites appear as brightly illuminated areas in contrast to the dark background (see Notes 2 and 3). The color of the light or fluorescence depends on the chromogen used: Fluorescein iso-thiocyanate (FITC) excites at 495 nm and emits green light (peak at 525 nm) whereas tetra-methyl rhodamine-iso-thiocyanate (TRITC) absorbs maximally at 552 nm and gives red fluorescence (peak at 570 nm). To detect fluorochrome labels special microscopes equipped with an UV-light source and appropriate filters are required. In immunoenzymatic stainings enzymes conjugated to antibodies react with appropriate substrates and generate color deposits on the samples. Distribution of the target antigens can thus be examined with a light microscope (see Note 4).
Keywords
- Cryostat Section
- Membrane Attack Complex
- Exciting Radiation
- Complement Regulator
- Complement Receptor Type
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Seya T., Turner J. R., and Atkinson J. P. (1986) Purification and characterization of a membrane protein (gp45–70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163, 837–855.
Nicholson-Weller A., Burge J., Fearon D. T., Weller P. F., and Austen K. F. (1982) Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 129, 184–189.
Sugita Y., Nakano Y., and Tomita M. (1988) Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement trans-membrane channels. J. Biochem. (Tokyo) 104, 633–637.
HφgÅsen K., Mollnes T. E., and Harboe M. (1992) Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex. J. Biol. Chem. 267, 23,076–23,082.
Lowell C. A., Klickstein L. B., Carter R. H., Mitchell J. A., Fearon D. T., and Ahearn J. M. (1989) Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2. J. Exp. Med. 170, 1931–1946.
Morgan B. P. (1995) Complement regulatory molecules: application to therapy and transplantation. Immunol. Today 16, 257–259.
Krych M., Atkinson J. P., and Holers V. M. (1992) Complement receptors. Curr. Opin. Immunol. 4, 8–13.
Meri S. and Jarva H. (1998) Complement regulation. Vox. Sang. 74, 291–302.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Hakulinen, J., Meri, S. (2000). Complement Regulators and Receptors in Tissues. In: Morgan, B.P. (eds) Complement Methods and Protocols. Methods in Molecular Biology, vol 150. Humana Press. https://doi.org/10.1385/1-59259-056-X:123
Download citation
DOI: https://doi.org/10.1385/1-59259-056-X:123
Publisher Name: Humana Press
Print ISBN: 978-0-89603-654-3
Online ISBN: 978-1-59259-056-8
eBook Packages: Springer Protocols